Cellestial Health
PrivateLast Round
Seed
Dec 2, 2025
Total Funding Raised
$1.18M
Company Overview
Cellestial Health operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Grant round in September 2025.
Cellestial Health is a biopharmaceutical company developing small molecule therapeutics designed to slow the progression of neurodegenerative diseases by targeting astrocytes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellestial Health Comparables
Compare Cellestial Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allyx Therapeutics, Inc. | 77% | |
| Astrocyte Pharmaceuticals Inc. | 77% | |
| NRG Therapeutics | 73% |
For institutional investors. Book with your work email.
Cellestial Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 2, 2025 | ||||
| Grant | Sep 19, 2025 | ||||
| Pre Seed | May 8, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellestial Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zinc | Pre Seed |
| Parkinson's UK | Grant |
| Alma Angels | Pre Seed |
| Cambridge Enterprise | Grant |
| SFC Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors increased 72% MoM.
- May 8, 2025
$654K raised in Pre Seed round.
For institutional investors. Book with your work email.
Cellestial Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellestial Health's valuation, stock price, and market status.
Is Cellestial Health a public or private company?
Cellestial Health is a private company.
What is the current stock price of Cellestial Health?
Cellestial Health is a private company, so its shares have no public market price. Caplight tracks Cellestial Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellestial Health worth (valuation)?
Valuation information for Cellestial Health is not publicly available.
Can I buy Cellestial Health stock?
Cellestial Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellestial Health's last funding round?
Cellestial Health's most recent funding round was Seed on December 2, 2025.
Who are the main investors in Cellestial Health?
Key investors in Cellestial Health include Zinc.
Will Cellestial Health IPO soon?
No public IPO plans have been announced for Cellestial Health.
How can I track Cellestial Health secondary market activity?
Caplight tracks bids, offers, and trades in Cellestial Health's shares on secondary markets.